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Abstract
Obstructive sleep apnea (OSA) is associated with cognitive impairment, daytime sleepiness, and
cardiovascular and cerebrovascular morbidity and mortality. Continuous positive airway pressure
(CPAP) remains the primary treatment for this disorder, and recent data provide novel insight
regarding optimal CPAP application and compliance. Promising alternate forms of OSA treatment
have also been addressed with recent clinical research.
Introduction and context
Obstructive sleep apnea (OSA), a prevalent disorder in
adults defined by repetitive upper-airway obstruction
and asphyxia, is associated with fatal and non-fatal
cardiovascular and cerebrovascular adverse effects [1-3].
Continuous positive airway pressure (CPAP) remains the
first-line treatment for this disorder, with randomized
controlled trials repeatedly demonstrating efficacy of
CPAP in improving OSA symptoms [4,5]. A preponder-
ance of current clinical research focuses on optimizing
application of, and compliance with, CPAP, which
appears to be essential for the successful treatment of
OSA-related morbidity and mortality [1].
Recent advances
CPAP and quality-adjusted life years
A 2009 review of randomized controlled trials up to
November 2006 analyzed incremental costs per quality-
adjusted life years and found that CPAP was more cost-
effective than oral appliances or conservative treatment
alone in the treatment of OSA [6].
Pressure variable and auto-titrating devices
Positive airway pressure (PAP) devices may be modified
to lower late inspiratory and/or early expiratory fixed
positive pressure in an attempt to minimize discomfort
and improve adherence with CPAP. Although standard
bilevel PAP therapy has not been shown to improve
compliance compared with CPAP [7], bilevel PAP with
flexible expiratory pressure was recently associated with
better compliance than a CPAP control group in OSA
patients previously poorly compliant with CPAP [8].
In contrast, a randomized controlled trial of expiratory
pressure-relief CPAP versus fixed-pressure CPAP in a
group of patients with moderate OSA found no between-
group difference regarding apnea hypopnea index
(AHI), subjective sleepiness, side effects, or compliance
at 7 weeks [9].
Auto-titrating CPAP, programmed with device-specific
algorithms such that airway pressure varies with the
requirements of the upper airway, has also been studied
in regard to compliance in numerous recent randomized
trials; these generally have shown compliance similar to
that of auto-titrating and fixed-pressure devices [10-13],
although one study did find that compliance was
significantly higher in the auto-titrating CPAP group
(up to 0.5-0.7 more hours per night than fixed CPAP)
[14]. Other sleep parameters, including AHI, were
essentially equivalent for fixed and auto-titrating CPAP
among these studies. Two recent randomized trials
investigated the efficacy of auto-adjusting CPAP applied
to OSA patients exclusively in the ambulatory setting.
CPAP compliance and improvement in subjective day-
time sleepiness were similar in a group randomly
assigned to ambulatory diagnostic and auto-titrating
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polysomnographic diagnosis and CPAP titration at
6-week follow-up [15]. A 3-month trial in patients with
a high probability of OSA demonstrated a similar AHI in
patients treated with auto-titrating CPAP alone and
patients who underwent polysomnographic diagnosis
and CPAP titration [16]. Sleep apnea-related quality of
life and subjective sleepiness were similarly improved in
the two groups, while CPAP compliance was higher in
the autotitrated CPAP group.
Adaptive servo-ventilation
A recent randomized crossover trial [17] demonstrated
that adaptive servo-ventilation (ASV), a form of bilevel
PAP which self-adjusts to a patient’s breathing pattern,
was significantly more effective than titrated bilevel PAP
with a back-up rate in decreasing the AHI in patients with
central and mixed sleep apneas, including ‘complex’
sleep apnea (an entity in which central apneas become
evident in OSA patients during CPAP application).
A review of 100 consecutive patients treated with ASV
for central sleep apnea, Cheyne-Stokes breathing, and/or
complex sleep apnea after unsuccessful CPAP titration,
similarly demonstrated overall superiority of ASV in
improving AHI compared with bilevel PAP with and
without a back-up rate, and compared with CPAP [18].
Other modalities for improving CPAP compliance
In the initial phase of the flexible bilevel PAP study noted
above [8], interventions including mask fitting, heated
humidification, pharmacologic nasal patency therapy as
indicated, and systematic education improved CPAP
compliance by 24%, confirming that a significant
portion of non-compliance with CPAP can be modu-
lated with these measures [19,20], as recommended in
the current practice parameters of the American Academy
of Sleep Medicine [21].
Other treatment modalities
Weight loss
While improvement of OSA has been demonstrated in
morbidly obese individuals with weight loss following
bariatric surgery [22,23], recent work indicates that
complete resolution of OSA is rarely achieved with
gastric banding despite significant weight loss [24]. More
recent data extend these findings to patients with lesser
degrees of obesity undergoing non-surgical weight loss:
in a population of obese patients (body mass index
28-40) with mild OSA (AHI 5-15), a very low calorie diet
for 12 weeks along with supervised dietary and exercise
counseling throughout a 1-year study period resulted in
significantly greater improvement in weight loss and
sleep-disordered breathing parameters (including AHI
and percentage time with oxygen saturation below 90%)
compared with a control group with minimal weight
loss intervention [25]. Cure rates for OSA (AHI <5) at
12 months were 63% in the intervention group and 35%
in the control group.
Positional therapy
A recent randomized crossover trial using a thoracic anti-
supine band that nearly abolished sleep in the supine
position demonstrated significant improvement in
AHI in most patients with mild to moderate supine-
predominant OSA [26]. However, this improvement was
significantly less than the improvement in AHI achieved
with CPAP in these patients.
Oral appliances
A recent randomized trial demonstrated that, in patients
with mild to moderate OSA, a mandibular advancement
device and CPAP each resulted in significant improve-
ment in sleep-disordered breathing, sleep apnea-related
quality of life, and morning diastolic blood pressure;
CPAP was more effective than the oral appliance in
decreasing sleep-disordered breathing and subjective
daytime sleepiness [27]. These data are consistent with
a recent meta-analysis that found that, although oral
appliances and CPAP similarly improve OSA symptoms,
oral appliances are generally inferior to CPAP in
improving objective sleep-disordered breathing para-
meters [28]. In the most recent update of the American
Academy of Sleep Medicine practice parameters, oral
appliances are suggested for patients with mild to
moderate OSA who do not respond to CPAP or who
prefer an oral appliance [29].
Cardiac resynchronization therapy
Two recent studies investigated the efficacy of cardiac
resynchronization therapy, with associated improve-
ment in hemodynamic function, in ameliorating OSA
diagnosed in patients with heart failure. One study
showed no significant effect [30]; the other [31] found
a significant decrease in the AHI, which, however,
remained in the range of moderate to severe (mean
AHI 29.5). In a recent randomized trial [32], atrial
overdrive pacing set at a rate of 15 beats higher than the
average nocturnal rate mildly improved AHI in this
setting but was inferior to the effect of CPAP.
Implications for clinical practice
Current data continue to support CPAP as primary
therapy for the treatment of OSA, particularly in patients
with severe OSA and those at high risk for cardiovascular
morbidity. Recent research confirms the efficacy of
interventions such as systematic education and mask
fitting in improving CPAP compliance. Consistent with a
previous meta-analysis that considered trials up to 2004
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iority of auto-titrating or pressure-relief CPAP to fixed-
pressure CPAP in regard to patient compliance or other
OSA variables. However, the use of such technology
regarding longer-term clinical outcomes remains to be
defined, and the applications of auto-titrating CPAP
exclusively in the outpatient setting in patients with a
high likelihood of OSA and of pressure-relief PAP in
patients poorly compliant with CPAP are particularly
promising. Weight loss should continue to be a major
treatment consideration in all overweight patients with
OSA. Oral appliances continue to represent a reasonable
alternative to CPAP, particularly in milder forms of the
disorder. Further studies of PAP regimens for OSA in
patients with heart failure and complex sleep apnea,
including ASV, are likely to better define the role of such
therapy in improving OSA outcomes in these settings.
Abbreviations
AHI, apnea hypopnea index; ASV, adaptive servo-
ventilation; CPAP, continuous positive airway pressure;
OSA, obstructive sleep apnea; PAP, positive airway
pressure.
Competing interests
RCB has been funded with an unrestricted grant from the
ResMed Foundation to study adaptive servo-ventilation
outcomes in patients with acute heart failure and
Cheyne-Stokes breathing. JAW declares that he has no
competing interests.
References
1. Campos-Rodriguez F, Peña-Griñan N, Reyes-Nuñez N, De la Cruz-
Moron I, Perez-Ronchel J, De la Vega-Gallardo F, Fernandez-Palacin A:
Mortality in obstructive sleep apnea-hypopnea patients
treated with positive airway pressure. Chest 2005, 128:624-33.
2. Marin JM, Carrizo SJ, Vicente E, Agusti AG: Long-term cardiovas-
cular outcomes in men with obstructive sleep apnoea-
hypopnoea with or without treatment with continuous
positive airway pressure: an observational study. Lancet 2005,
365:1046-53.
3. Peppard PE, Young T, Palta M, Skatrud J: Prospective study of the
association between sleep-disordered breathing and hyper-
tension. N Engl J Med 2000, 342:1378-84.
4. Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates CJ:
Continuous positive airways pressure for obstructive sleep
apnoea in adults. Cochrane Database Syst Rev 2006, 3:CD001106.
5. Basner RC: Continuous positive airway pressure for obstruc-
tive sleep apnea. N Engl J Med 2007, 356:1751-8.
6. McDaid C, Griffin S, Weatherly H, Durée K, van der Burgt M, van
Hout S, Akers J, Davies RJ, Sculpher M, Westwood M: Continuous
positive airway pressure for the treatment of obstructive
sleep apnoea-hypopnoea syndrome: a systematic review and
economic analysis. Health Technol Assess 2009, 13:1-274.
7. Haniffa M, Lasserson TJ, Smith I: Interventions to improve
compliance with continuous positive airway pressure for
obstructive sleep apnoea. Cochrane Database Syst Rev 2004,
CD003531.
8. Ballard RD, Gay PC, Strollo PJ: Interventions to improve
compliance in sleep apnea patients previously non-compliant
with continuous positive airway pressure. J Clin Sleep Med 2007,
3:706-12.
9. Nilius G, Happel A, Domanski U, Ruhle KH: Pressure-relief
continuous positive airway pressure vs constant continuous
positive airway pressure: a comparison of efficacy and
compliance. Chest 2006, 130:1018-24.
10. Fietze I, Glos M, Moebus I, Witt C, Penzel T, Baumann G: Automatic
pressure titration with APAP is as effective as manual
titration with CPAP in patients with obstructive sleep
apnea. Respiration 2007, 74:279-86.
11. Mulgrew AT, Cheema R, Fleetham J, Ryan CF, Ayas NT: Efficacy and
patient satisfaction with autoadjusting CPAP with variable
expiratory pressure vs standard CPAP: a two-night rando-
mized crossover trial. Sleep Breath 2007, 11:31-7.
12. Nolan GM, Doherty LS, Mc Nicholas WT: Auto-adjusting versus
fixed positive pressure therapy in mild to moderate obstruc-
tive sleep apnoea. Sleep 2007, 30:189-94.
13. Nussbaumer Y, Bloch KE, Genser T, Thurnheer R: Equivalence of
autoadjusted and constant continuous positive airway pres-
sure in home treatment of sleep apnea. Chest 2006, 129:638-43.
14. To KW, Chan WC, Choo KL, Lam WK, Wong KK, Hui DS:
A randomized cross-over study of auto-continuous positive
airway pressure versus fixed-continuous positive airway
pressure in patients with obstructive sleep apnoea. Respirology
2008, 13:79-86.
15. Berry RB, Hill G, Thompson L, McLaurin V: Portable monitoring
and autotitration versus polysomnography for the diagnosis
and treatment of sleep apnea. Sleep 2008, 31:1423-31.
F1000 Factor 3.0 Recommended
Evaluated by James A Rowley 24 Feb 2009
16. Mulgrew AT, Fox N, Ayas NT, Ryan CF: Diagnosis and initial
management of obstructive sleep apnea without polysomno-
graphy: a randomized validation study. Ann Intern Med 2007,
146:157-66.
F1000 Factor 3.0 Recommended
Evaluated by James A Rowley 11 Apr 2007
17. Morgenthaler TI, Gay PC, Gordon N, Brown LK: Adaptive
servoventilation versus noninvasive positive pressure ventila-
tion for central, mixed, and complex sleep apnea syndromes.
Sleep 2007, 30:468-75.
18. Allam JS, Olson EJ, Gay PC, Morgenthaler TI: Efficacy of adaptive
servoventilation in treatment of complex and central sleep
apnea syndromes. Chest 2007, 132:1839-46.
19. Hoy CJ, Vennelle M, Kingshott RN, Engleman HM, Douglas NJ: Can
intensive support improve continuous positive airway pres-
sure use in patients with the sleep apnea/hypopnea syn-
drome? Am J Respir Crit Care Med 1999, 159:1096-100.
20. Massie CA, Hart RW, Peralez K, Richards GN: Effects of
humidification on nasal symptoms and compliance in sleep
apnea patients using continuous positive airway pressure.
Chest 1999, 116:403-8.
21. Kushida CA, Littner MR, Hirshkowitz M, Morgenthaler TI, Alessi CA,
Bailey D, Boehlecke B, Brown TM, Coleman J Jr, Friedman L, Kapen S,
Kapur VK, Kramer M, Lee-Chiong T, Owens J, Pancer JP, Swick TJ,
Wise MS: Practice parameters for the use of continuous and
bilevel positive airway pressure devices to treat adult patients
with sleep-related breathing disorders. Sleep 2006, 29:375-80.
22. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W,
Fahrbach K, Schoelles K: Bariatric surgery: a systematic review
and meta-analysis. JAMA 2004, 292:1724-37.
23. Dixon JB, Schachter LM, O’Brien PE: Polysomnography before
and after weight loss in obese patients with severe sleep
apnea. Int J Obes (Lond) 2005, 29:1048-54.
24. Lettieri CJ, Eliasson AH, Greenburg DL: Persistence of obstructive
sleepapneaaftersurgicalweightloss.JClinSleepMed2008,4:333-8.
25. Tuomilehto HP, Seppa JM, Partinen MM, Peltonen M, Gylling H,
Tuomilehto JO, Vanninen EJ, Kokkarinen J, Sahlman JK, Martikainen T,
Page 3 of 4
(page number not for citation purposes)
F1000 Medicine Reports 2009, 1:48 http://F1000.com/Reports/Medicine/content/1/48Soini EJ, Randell J, Tukiainen H, Uusitupa M: Lifestyle intervention
with weight reduction: first-line treatment in mild obstruc-
tive sleep apnea. Am J Respir Crit Care Med 2009, 179:320-7.
26. Skinner MA, Kingshott RN, Filsell S, Taylor DR: Efficacy of the
‘tennis ball technique’ versus nCPAP in the management of
position-dependent obstructive sleep apnoea syndrome.
Respirology 2008, 13:708-15.
27. Lam B, Sam K, Mok WY, Cheung MT, Fong DY, Lam JC, Lam DC,
Yam LY, Ip MS: Randomised study of three non-surgical
treatments in mild to moderate obstructive sleep apnoea.
Thorax 2007, 62:354-9.
28. Lim J, Lasserson TJ, Fleetham J, Wright J: Oral appliances for
obstructive sleep apnoea. Cochrane Database Syst Rev 2006,
CD004435.
29. Kushida CA, Morgenthaler TI, Littner MR, Alessi CA, Bailey D,
Coleman J Jr, Friedman L, Hirshkowitz M, Kapen S, Kramer M, Lee-
Chiong T, Owens J, Pancer JP; American Academy of Sleep: Practice
parameters for the treatment of snoring and Obstructive
Sleep Apnea with oral appliances: an update for 2005. Sleep
2006, 29:240-3.
30. Oldenburg O, Faber L, Vogt J, Dorszewski A, Szabados F,
Horstkotte D, Lamp B: Influence of cardiac resynchronisation
therapy on different types of sleep disordered breathing. Eur J
Heart Failure 2007, 9:820-6.
31. Stanchina ML, Ellison K, Malhotra A, Anderson M, Kirk M, Benser ME,
Tosi C, Carlisle C, Millman RP, Buxton A: The impact of cardiac
resynchronization therapy on obstructive sleep apnea in
heart failure patients: a pilot study. Chest 2007, 132:433-9.
32. Sharafkhaneh A, Sharafkhaneh H, Bredikus A, Guilleminault C,
Bozkurt B, Hirshkowitz M: Effect of atrial overdrive pacing on
obstructive sleep apnea in patients with systolic heart failure.
Sleep Med 2007, 8:31-6.
Page 4 of 4
(page number not for citation purposes)
F1000 Medicine Reports 2009, 1:48 http://F1000.com/Reports/Medicine/content/1/48